8037 — China Biotech Services Holdings Share News
0.000.00%
- HK$482.99m
- HK$924.61m
- HK$73.50m
Brief: China Biotech Services Says Trading In Co's Shares Halted
Brief: China Biotech Services Says QTRLY Profit Hk$81.8 Million Versus Loss Of Hk$21.1 Million
Brief: Ko Chun Shun Johnson's Long Position In China Biotech Services Rises To 9.90% - HKEX Filing
Brief: China Biotech Services Saya Unit & BGI Health (HK) Co Entered Master Supply Agreement
Chairman & Executive Director
Brief: China Biotech Services Holdings Ltd Sees A Net Profit Of Not Less Than HK$26 Million For Q1
Brief: China Biotech Services Says Leung Pak Hou Anson To Retire As An Executive Director
Brief: China Biotech Services Says Unit And BGI Entered Into Master Services Agreement
Brief: China Biotech Services Sees Net Profit Of Not Less Than HK$140 Mln For 2020
Brief: China Biotech Services Says Shanghai Longyao Received Approval For Clinical Trial For Product LY007 Cellular Injection
Brief: China Biotech Services Holdings Says Qtrly Profit Attributable HK$61.8 Mln
Brief: China Biotech Services Says Unit Applied To CDE For Registration Of Clinical Trial Of LY007
Brief: China Biotech Services Sees Net Profit Of Not Less Than HK$130 Mln For Q3 2020
Brief: China Biotech Services Unit & BGI Entered Master Services Agreement
Brief: China Biotech Services Says Unit Entered Agreement Relating To Candidate Vaccine For COVID-19
Brief: China Biotech Services Partnered With BGI Health (HK) Co
Brief: China Biotech Services Holdings Says Sees Net Loss Of Not Less Than HK$45 Mln For HY
Brief: China Biotech Services Posts QTRLY Loss Attributable Hk$22.1 Million
Brief: China Biotech Services Sees Qtrly Net Loss Of Not Less Than HK$24 Mln